Zerila Therapeutics News | Page 6 of 7 | Cannabiz

Zelira offers Hope to autism patients

by Martin Lane October 28, 2020April 26, 2024

Zelira Therapeutics’ Hope range of autism cannabinoid medicines are now available to Australian patients by prescription […]

Emyria and Zelira sign patient data deal for insomnia treatment

by Martin Lane October 1, 2020April 26, 2024

Zelira Therapeutics launches Zenivol insomnia product in Australia

by Emma Castle September 17, 2020April 22, 2024

Analysis: The battle to restore value to the Australian cannabis sector

by Steve Jones August 27, 2020April 22, 2024

Your daily dose of cannabis news: Zelira MD shows faith; Medical Kiwi’s crowdfunding success; NZ firms ink deal

by Martin Lane August 18, 2020April 22, 2024

Investors still attracted to low-cost, high-margin cannabis businesses

by Martin Lane August 11, 2020April 22, 2024

Your daily dose of cannabis news: MS Australia backs Sativex bid; Medlab’s new board member; Zelira completes cap raising; MGC Pharma trading halt

by Martin Lane August 6, 2020April 22, 2024

Your daily dose of cannabis news: Little Green Pharma’s government boost; Zelira Therapeutics’ capital raising; THC Global plans growth

by Martin Lane August 4, 2020April 22, 2024

Your daily dose of cannabis news: Ecofibre’s US acquisition; Zelira Therapeutics requests trading halt; Aussie kids and cannabis

by Martin Lane July 30, 2020April 22, 2024

Your daily dose of cannabis news: cannabis vs Covid-19; cannabis vs diabetes and heart disease; MGC Pharma in trading halt

by Martin Lane July 23, 2020April 22, 2024